News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
10 09 2015 The new Quest test service is based on the first FDA-approved complementary diagnosticQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx...
-
10 08 2015 Scientists from Quest Diagnostics also provide an oral presentation on the novel "molecular combing" technique's ability to identify gene mutations to aid diagnosis of a form of muscular dystrophyGenetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a...
-
10 06 2015 Molecular test from Quest Diagnostics' products business is cleared to identify 92 influenza and respiratory syncytial virus strains, more than any other FDA-cleared molecular testIn advance of the 2015-2016 flu season, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received 510(k)...
-
10 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2015 results on Thursday, October 22, 2015,...
-
10 02 2015 Testing by Quest will advance precision medicine by helping to identify patients who may benefit from new oncology immunotherapyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the PD-L1 IHC 22C3 PharmDx™...
-
09 29 2015 "Data Diagnostics™" provides valuable on-demand insights to align clinical management with quality, utilization and financial performance goalsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based data...
-
09 14 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the eleventh consecutive year in the North America Dow Jones Sustainability Index...
-
09 11 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
-
09 10 2015 Analysis by Quest Diagnostics of 2.5 million de-identified test results finds about half of patients of all ages are still taking opioids and other potentially addictive medications inappropriatelyAlthough prescription drug misuse is on the decline among adolescents, one in two patients tested between the ages of 10 and 17 years are not using their medications appropriately, potentially...
-
09 10 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 10th Annual Wells Fargo Healthcare...